Your session is about to expire
← Back to Search
Blood Flow Restriction Exercise for Multiple Sclerosis (BRAVe-MS Trial)
BRAVe-MS Trial Summary
This trial will study the effects of strength training using blood flow restriction in people with advanced disability due to MS. The goal is to help improve strength, mobility, fatigue, and quality of life.
BRAVe-MS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBRAVe-MS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BRAVe-MS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My MS allows me to do daily activities without help.I have other health conditions or pain that affect my physical abilities.I cannot do a seated leg press or fully straighten my knee against gravity in at least one leg.I cannot sit in a wheelchair for more than an hour.My legs are very stiff, scoring over 2 on a spasticity scale.I need a cane to walk because of my condition.I have a history of blood clots or clotting disorders.I need help to walk.I bruise easily.I have not used blood flow restriction in the last 2 months.I have been diagnosed with multiple sclerosis.I am between 18 and 75 years old.I haven't had an MS flare-up or changed my MS medication in the last month.I need a cane to walk because of my condition.I use a wheelchair or scooter for mobility.
- Group 1: Low-Load Exercise with Blood Flow Restriction
- Group 2: Low-Load Exercise Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible to be a part of this clinical investigation?
"To be eligible for inclusion in this medical trial, participants should have been diagnosed with multiple sclerosis and must fall between the ages of 18-70. The goal is to recruit a total of 58 patients."
Are there any vacancies left within this research trial?
"The clinicaltrials.gov website informs us that this study, originally posted on January 1st 2023 and last updated on November 3rd 2022, is not presently open for recruitment. However, 553 other medical trials are currently in the process of finding suitable patients."
Are individuals over the age of 35 eligible to participate in this trial?
"The need for participants in this particular medical trial is limited to individuals aged 18 - 70. However, there are 44 trials available for minors and 394 clinical studies that cater specifically to patients 65 years old or older."
Share this study with friends
Copy Link
Messenger